Ipratropium Nasal Spray: Generic Alternative to Atrovent

  Published 1 year ago

Ipratropium Bromide Nasal Solution is a bioequivalent to Atrovent for treating rhinorrhea in adults and children aged 6+; U.S. sales reached $63M in May 2025.

  • Lupin, a global pharmaceutical leader, offers this solution in over 100 markets with diverse product portfolios.
  • Indicated for allergic and nonallergic perennial rhinitis, providing symptomatic relief for nasal discharge.
  • IQVIA data shows $63 million in annual U.S. sales in May 2025 for the RLD Atrovent equivalent formulation.

You might like these

Atul Auto's 3-Wheeler Sales Growth in 2025

Indian Steel Stocks Surge on Import Decline

India Census 2027: Caste Data & Delays

Hindustan Zinc Stock Plummets 6% Amid Vedanta Stake Sale

Meta & Thailand Partner on Privacy Education

Shyam Metalics Q1 Sales Jump 22%

Ola Electric Shares Dip on Pledge & Sales Concerns

News that matters the most ⚡